These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3293818)

  • 21. Antimicrobial activity of tigecycline tested against organisms causing community-acquired respiratory tract infection and nosocomial pneumonia.
    Fritsche TR; Sader HS; Stilwell MG; Dowzicky MJ; Jones RN
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):187-93. PubMed ID: 16105563
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro study to compare sensitivity of amoxicillin+clavulanic acid and cefpodoxime+clavulanic acid among beta-lactamase positive clinical isolates of gram-positive and gram-negative pathogens.
    Pal RB; Pal P; Jain S; Kulkarni KP
    J Indian Med Assoc; 2008 Aug; 106(8):545-8. PubMed ID: 18975519
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antimicrobial activity of cefepime tested against ceftazidime-resistant Gram-negative clinical strains from North American Hospitals: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
    Pfaller MA; Sader HS; Fritsche TR; Jones RN
    Diagn Microbiol Infect Dis; 2006 Sep; 56(1):63-8. PubMed ID: 16650951
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [In vitro activity of norfloxacin against gram-positive and gram-negative organisms from recent clinical isolates].
    Mancini C; Brenciaglia MI; Ghezzi MC; Giordano A; Nazzari C; Cipriani P
    Boll Ist Sieroter Milan; 1985; 64(4):289-93. PubMed ID: 3935135
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antimicrobial resistance of Gram-negative bacilli isolates from inpatients and outpatients at Yaounde Central Hospital, Cameroon.
    Piéboji JG; Koulla-Shiro S; Ngassam P; Adiogo D; Njine T; Ndumbe P
    Int J Infect Dis; 2004 May; 8(3):147-54. PubMed ID: 15109589
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Susceptibility of clinically-isolated problem pathogenic bacteria to broad spectrum antibiotics].
    Fazli SA; Aksebzeci T
    Mikrobiyol Bul; 1989 Oct; 23(4):356-60. PubMed ID: 2488944
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The antimicrobial activity of Augmentin (amoxicillin/clavulanic acid) compared to other antibacterial agents].
    Zubkov MN; Nonikov VE; Gugutsidze EN; Sutormina TM; Makarova OV
    Antibiot Khimioter; 1992 Sep; 37(9):34-6. PubMed ID: 1444669
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In-vitro comparison of ceftazidime and nine other antimicrobial agents against hospital strains of Gram-negative bacteria.
    Wilkinson LD; Gentry LO
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():53-6. PubMed ID: 19802969
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sensitivity of clinical isolates from German hospitals to amoxicillin/clavulanic acid (Augmentin) compared with other antibiotics.
    Focht J; Klietmann W; Nösner K; Rolinson GN; Johnsen J
    Chemotherapy; 1988; 34(4):332-40. PubMed ID: 3264780
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of protein binding on the pharmacodynamics of ceftazidime or ceftriaxone against gram-positive and gram-negative bacteria in an in vitro infection model.
    Scaglione F; Demartini G; Arcidiacono MM; Dugnani S; Fraschini F
    J Chemother; 1998 Feb; 10(1):29-34. PubMed ID: 9531073
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative in vitro activity of the new oral cephalosporin cefixime.
    Counts GW; Baugher LK; Ulness BK; Hamilton DJ
    Eur J Clin Microbiol Infect Dis; 1988 Jun; 7(3):428-31. PubMed ID: 3137053
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro activity of tigemonam against multiresistant nosocomial Enterobacteriaceae.
    Giamarellou H; Pephanis A; Grammatikou M; Avlamis A; Papoulias G
    J Chemother; 1989 May; 1 Suppl 2():32-5. PubMed ID: 2809700
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro comparison of GR69153, a novel catechol-substituted cephalosporin, with ceftazidime and ceftriaxone against 5,203 recent clinical isolates.
    Washington JA; Jones RN; Allen SD; Gerlach EH; Koontz FP; Murray PR; Pfaller MA; Erwin ME
    Antimicrob Agents Chemother; 1991 Jul; 35(7):1508-11. PubMed ID: 1929319
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Differences in sensitivity to Augmentin (and other antibiotics) of Staphylococcus aureus strains isolated from various specimens and patients from different clinics].
    Ruczkowska J; Dolna I
    Przegl Lek; 1990; 47(10):702-5. PubMed ID: 2089448
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In-vitro activity of ceftazidime compared with other beta-lactam antibiotics.
    Clarke AM; Zemcov SJ
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():57-62. PubMed ID: 19810169
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro activity of cefepime and cefpirome compared to other third-generation cephem antibiotics against gram-negative nosocomial pathogens.
    Tumah HN
    Pharmazie; 2004 Nov; 59(11):854-8. PubMed ID: 15587586
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative in vitro activity of augmentin against community and hospital-acquired gram-negative bacteria.
    Glupczynski Y; McGillavry G; Yourassowsky E
    Acta Clin Belg; 1988; 43(2):109-14. PubMed ID: 3400375
    [No Abstract]   [Full Text] [Related]  

  • 38. Augmentin: laboratory studies.
    Farrell ID; Turner PJ
    Scott Med J; 1982; 27 Spec No.():S21-3. PubMed ID: 6762661
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comparative in vitro study of the antimicrobial activity of ceftazidime against clinical isolates].
    Klietmann W; Focht J; Nösner K
    Infection; 1987; 15 Suppl 4():S145-9. PubMed ID: 3312026
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multicenter comparison of in vitro activities of FK-037, cefepime, ceftriaxone, ceftazidime, and cefuroxime.
    Washington JA; Jones RN; Gerlach EH; Murray PR; Allen SD; Knapp CC
    Antimicrob Agents Chemother; 1993 Aug; 37(8):1696-700. PubMed ID: 8215286
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.